Transplant International

Article	Citations
Why the immune system fails to mount an adaptive immune response to a COVID‐19 infection	111
COVID‐19 in solid organ transplant recipients: a single‐center experience	70
Management of post‐transplant diabetes: immunosuppression, early prevention, and novel antidiabetics	54
A systematic review and meta‐analyses of regional perfusion in donation after circulatory death solid organ transplantation	53
Impact of COVID‐19 on liver transplantation in Europe: alert from an early survey of European Liver and Intestine Transplantation Association and European Liver Transplant Registry	47
Consensus statement on normothermic regional perfusion in donation after circulatory death: Report from the European Society for Organ Transplantation’s Transplant Learning Journey	40
The impact of COVID‐19 on kidney transplantation and the kidney transplant recipient – One year into the pandemic	37
Treatment of transplant kidneys during machine perfusion	32
SARS‐CoV‐2 vaccination in solid‐organ transplant recipients: What the clinician needs to know	32
Donor‐derived cell‐free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta‐analysis	30
Generation of insulin‐secreting organoids: a step toward engineering and transplanting the bioartificial pancreas	29
Recovery of kidney function after AKI because of COVID‐19 in kidney transplant recipients	27
Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score	26
Donation after circulatory death liver transplantation: consensus statements from the Spanish Liver Transplantation Society	24
Abstracts	23
Organ donation during the coronavirus pandemic: an evolving saga in uncharted waters	23
Machine learning to predict transplant outcomes: helpful or hype? A national cohort study	23
How to guarantee liver transplantation in the north of Italy during the COVID‐19 pandemic: A sound transplant protection strategy	22
Organ utilization – the next hurdle in transplantation?	22
Stratifying the humoral risk of candidates to a solid organ transplantation: a proposal of the ENGAGE working group	22
Recurrence of primary sclerosing cholangitis after liver transplantation – analysing the European Liver Transplant Registry and beyond	22
eHealth in transplantation	21
Machine learning in liver transplantation: a tool for some unsolved questions?	20
COVID‐19 and education: restructuring after the pandemic	20
Suspension and resumption of kidney transplant programmes during the COVID‐19 pandemic: perspectives from patients, caregivers and potential living donors – a qualitative study	20

Magnetic resonance imaging assessment of renal flow distribution patterns during ex vivo normothermic machine perfusion in porcine and human kidneys	19
Human liver stem cell‐derived extracellular vesicles reduce injury in a model of normothermic machine perfusion of rat livers previously exposed to a prolonged warm ischemia	19
Clinical outcomes associated with computed tomography‐based body composition measures in lung transplantation: a systematic review	18
Successful kidney transplantation after COVID‐19	18
Organoid transplant approaches for the liver	17
The prognosis of kidney transplant recipients with aorto‐iliac calcification: a systematic review and meta‐analysis	17
A retrospective single‐centre analysis of the oncological impact of LI‐RADS classification applied to Metroticket 2.0 calculator in liver transplantation: every nodule matters	17
Molecular‐level HLA mismatch is associated with rejection and worsened graft survival in heart transplant recipients – a retrospective study	17
Pediatric acute graft‐versus‐host disease prophylaxis and treatment: surveyed real‐life approach reveals dissimilarities compared to published recommendations	17
A catabolic state in a kidney transplant recipient with COVID‐19	17
An extension of the RITUX‐ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody‐mediated rejection after renal transplantation	17
Undoubtedly, kidney transplant recipients have a higher mortality due to COVID‐19 disease compared to the general population	16
A subcutaneous pancreatic islet transplantation platform using a clinically applicable, biodegradable Vicryl mesh scaffold ‐ an experimental study	16
Safety and efficacy of direct‐acting oral anticoagulants versus warfarin in kidney transplant recipients: a retrospective single‐center cohort study	16
Association of graft survival with tacrolimus exposure and late intra‐patient tacrolimus variability in pediatric and young adult renal transplant recipients—an international CTS registry analysis	16
Kidney transplantation and the lockdown effect	15
Simultaneous liver kidney allocation policy and the Safety Net: an early examination of utilization and outcomes in the United States	15
Eosinophils in transbronchial biopsies: a predictor of chronic lung allograft dysfunction and reduced survival after lung transplantation — a retrospective single‐center cohort study	15
Successful pancreas allotransplantations after hypothermic machine perfusion in a novel diabetic porcine model: a controlled study	15
Diagnostic value of donor‐derived cell‐free DNA to predict antibody‐mediated rejection in donor‐specific antibody‐positive renal allograft recipients	15
Kidney transplant recipient perspectives on telehealth during the COVID‐19 pandemic	15
Exploring the causes of the high incidence of delayed graft function after kidney transplantation in Brazil: a multicenter study	15
Relative survival and quality of life benefits of pancreas–kidney transplantation, deceased kidney transplantation and dialysis in type 1 diabetes mellitus—a probabilistic simulation model	14
The emergence of regenerative medicine in organ transplantation: 1st European Cell Therapy and Organ Regeneration Section meeting	14
Are the outcomes of Japanese pancreas transplantation utilizing extended‐criteria donors acceptable? A propensity score matching analysis for donors <50 or ≥50 years old	13
Long‐term outcome after hand and forearm transplantation – a retrospective study	12
Kidney exchange strategies: new aspects and applications with a focus on deceased donor‐initiated chains	12
Changes in quality of life, health status and other patient‐reported outcomes following simultaneous pancreas and kidney transplantation (SPKT): a quantitative and qualitative analysis within a UK‐wid	12
A 2020 Banff Antibody‐mediatedInjury Working Group examination of international practices for diagnosing antibody‐mediated rejection in kidney transplantation – a cohort study	12
Solid organ transplantation is not a risk factor for COVID‐19 disease outcome	12
Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases	12
Early intestinal complications following pancreas transplantation: lessons learned from over 300 cases – a retrospective single‐center study	12
Considering extended right lobe grafts as major extended donor criteria in liver transplantation is justified	11
The effects of exercise training in adult solid organ transplant recipients: A systematic review and meta‐analysis	11
An analysis of the outcomes in living donor liver transplantation for pediatric malignant hepatic tumors using nationwide survey data in Japan	11
Regulatory B cells in transplantation: roadmaps to clinic	11
Impact of belatacept conversion on kidney transplant function, histology, and gene expression ‐ a single‐center study	11
Center volume and primary graft dysfunction in patients undergoing lung transplantation in the United States – a cohort study	11
Global Kidney Exchange: opportunity or exploitation? An ELPAT/ESOT appraisal	11
Cellular therapies in organ transplantation	11
Early pulmonary function and mid‐term outcome in lung transplantation afterex‐vivolung perfusion – a single‐center, retrospective, observational, cohort study	11
Donor helper innate lymphoid cells are replaced earlier than lineage positive cells and persist long‐term in human intestinal grafts – a descriptive study	10
Liver transplantation in patients with sickle cell disease: possible but challenging—a cohort study	10
Laparoscopic sleeve gastrectomy for morbid obesity in renal transplantation candidates: a matched case–control study	10
Disease‐specific waitlist outcomes in liver transplantation – a retrospective study	10
COVID‐19 among kidney‐transplant recipients requiring hospitalization: preliminary data and outcomes from a single‐center in Brazil	10
A systematic review and meta‐analysis on the incidence of osteoporosis and fractures after liver transplant	10
Successful liver transplantation immediately after recovery from COVID‐19 in a highly endemic area	10
Paired kidney exchange transplantation – pushing the boundaries	10
Should kidney allografts from old donors be allocated only to old recipients?	10

Prognostic role of the Donor Risk Index, the Eurotransplant Donor Risk Index, and the Balance of Risk score on graft loss after liver transplantation	10
Successful 18‐h acellular extracorporeal perfusion and replantation of porcine limbs ‐ Histology versus nerve stimulation	10
Trends in indications and outcomes of liver transplantation in Canada: A multicenter retrospective study	10
Have we reached the limits in altruistic kidney donation?	10
The evolution of histological changes suggestive of antibody‐mediated injury, in the presence and absence of donor‐specific anti‐HLA antibodies	10
Editorial: changing of the guard at Transplant International	10
Mini‐organs forum: how to advance organoid technology to organ transplant community	10
US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?	10
Clinical outcomes in donors and recipients of kidney transplantations involving medically complex living donors – a retrospective study	10
Autologous regulatory T cells in clinical intraportal allogenic pancreatic islet transplantation	10
ABO‐incompatible kidney transplantation in perspective of deceased donor transplantation and induction strategies: a propensity‐matched analysis	9
The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation	9
Organ transplants of the future: planning for innovations including xenotransplantation	9
De novo HLA Class II antibodies are associated with the development of chronic but not acute antibody‐mediated rejection after liver transplantation – a retrospective study	9
Clinical implementation of coronary computed tomography angiography for routine detection of cardiac allograft vasculopathy in heart transplant patients	9
Assessment of the global practice of living donor liver transplantation	9
Th17 cell inhibition in a costimulation blockade‐based regimen for vascularized composite allotransplantation using a nonhuman primate model	9
Proteomic analysis of machine perfusion solution from brain dead donor kidneys reveals that elevated complement, cytoskeleton and lipid metabolism proteins are associated with 1‐year outcome	9
Cell therapy during machine perfusion	9
Short recipient warm ischemia time improves outcomes in deceased donor liver transplantation	9
Short‐ and long‐term results of liver transplantation according to age at transplant: a single‐center experience of 351 children	9
Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long‐term benefits	9
Impact of coronavirus disease 2019 on organ donation and transplantation in France	9
The trials and tribulations of liver allocation	9
Safety and efficacy of direct oral anticoagulants under long‐term immunosuppressive therapy after liver, kidney and pancreas transplantation	9
Effect of pre‐transplant sarcopenia on the estimation of standard liver volume in living‐donor liver transplant candidates: risk factor for post‐transplant small‐for‐size syndrome? A retrospective stu	9
Global kidney exchange should expand wisely	9
EBV‐specific cytotoxic T lymphocytes for refractory EBV‐associated post‐transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review	9
Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis	9
The impact of functional delayed graft function in the modern era of kidney transplantation – A retrospective study	9
Recurrence of primary sclerosing cholangitis after liver transplantation is associated with specific changes in the gut microbiome pretransplant – a pilot study	8
Bisphosphonate therapy after liver transplant improves bone mineral density and reduces fracture rates: an updated systematic review and meta‐analysis	8
Pancreas collagen digestion during islet of Langerhans isolation—a prospective study	8
Guiding therapeutic plasma exchange for antibody‐mediated rejection treatment in lung transplant recipients – a retrospective study	8
Hypothermic oxygenated machine perfusion of the human pancreas for clinical islet isolation: a prospective feasibility study	8
Safe use of right lobe living donor livers with moderate steatosis in adult‐to‐adult living donor liver transplantation: a retrospective study	8
Pre‐transplant donor‐specific HLA antibodies and risk for poor first‐year renal transplant outcomes: results from the Swiss Transplant Cohort Study	8
Impact on biliary complications of donor abdominal aortic calcification among living donor liver transplantation: a retrospective study	8
Correcting anemia and native vitamin D supplementation in kidney transplant recipients: a multicenter, 2 × 2 factorial, open‐label, randomized clinical trial	8
Anti‐HLA and anti‐SARS‐CoV‐2 antibodies in kidney transplant recipients with COVID‐19	8
Impact of unilateral diaphragm elevation on postoperative outcomes in bilateral lung transplantation – a retrospective single‐center study	8
Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation	8
Full‐left‐full‐right split liver transplantation for adult recipients: a systematic review and meta‐analysis	8
Outcomes of simultaneous pancreas and kidney transplants based on preemptive transplant compared to those who were on dialysis before transplant – a retrospective study	8
Clinical value and limitations of the preoperative C‐reactive‐protein‐to‐albumin ratio in predicting post‐operative morbidity and mortality after deceased‐donor liver transplantation: a retrospective	8
COVID‐19 in lung transplant recipients: an overview of the Swedish national experience	8
Association of immigration background with kidney graft function in a publicly funded health system: a nationwide retrospective cohort study in Italy	8
Conditional probability of graft survival in liver transplantation using donation after circulatory death grafts – a retrospective study	8
Health‐related quality of life, uncertainty and coping strategies in solid organ transplant recipients during shielding for the COVID‐19 pandemic	7
Utilization of extracorporeal membrane oxygenation in DCD and DBD lung transplants: a 2‐year single‐center experience	7
The real incidence of biliary tract complications after adult liver transplantation: the role of the prospective routine use of cholangiography during post‐transplant follow‐up	7
Pancreas utilization rates in the UK – an 11‐year analysis	7
Ex vivo perfusion in lung transplantation and removal of HCV: the next level	7
Distinct molecular and immunological properties of circulating exosomes isolated from pediatric lung transplant recipients with bronchiolitis obliterans syndrome ‐ a retrospective study	7
Cost analysis of a long‐term randomized controlled study in biliary duct‐to‐duct anastomotic stricture after liver transplantation	7
Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution	7
Donor hepatitis C antibody positivity misclassifies kidney donor profile index in non‐hepatitis C‐infected donors: time to revise the kidney donor profile index – a retrospective cohort study	7
Influence of donor‐transmitted coronary artery disease on long‐term outcomes after heart transplantation ‐ a retrospective study	7
Managing immunosuppressive therapy in potentially cured post‐kidney transplant cancer (excluding non‐melanoma skin cancer): an overview of the available evidence and guidance for shared decision‐makin	7
Association between procurement biopsy findings and deceased donor kidney outcomes: a paired kidney analysis	7
Malignancy following heart transplantation: differences in incidence and prognosis between sexes – a multicenter cohort study	7
Graft utilization after normothermic regional perfusion in controlled donation after circulatory death—a single‐center perspective from France	7
Kidney transplantation and patients who decline SARS‐CoV‐2 vaccination: an ethical framework	7
The tacrolimus metabolism affect post‐transplant outcome mediating acute rejection and delayed graft function: analysis from Korean Organ Transplantation Registry data	7
Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism	7
Non‐simultaneous kidney exchange cycles in resource‐restricted countries without non‐directed donation – a prospective single‐center cohort study	7
Dealing with uncertainty after transplantation in times of COVID‐19	6
Application of ischaemia‐free liver transplantation improves prognosis of patients with steatotic donor livers – a retrospective study	6
Intravenous immunoglobulins do not prove beneficial to reduce alloimmunity among kidney transplant recipients with BKV‐associated nephropathy	6
Addressing ethical confusion in deceased donation and transplantation research: the need for dedicated guidance	6
The impact of severe acute kidney injury requiring renal replacement therapy on survival and renal function of heart transplant recipients – a UK cohort study	6
Lower donated kidney volume is associated with increased risk of lower graft function and acute rejection at 1 year after living donor kidney—a retrospective study	6
Metabolic outcomes and renal function after simultaneous kidney/pancreas transplantation compared with kidney transplantation alone for type 2 diabetes mellitus patients	6
Stable and safe organ procurement and transplantation during SARS‐CoV‐2 pandemic in Germany	6
Liver transplantation for congenital hepatic fibrosis	6
Early postoperative calculation of the tacrolimus concentration‐to‐dose ratio does not predict outcomes after kidney transplantation	6
Decreased incidence of acute rejection without increased incidence of cytomegalovirus (CMV) infection in kidney transplant recipients receiving rabbit anti‐thymocyte globulin without CMV prophylaxis –	6
Lung transplantation from uncontrolled and controlled donation after circulatory death: similar outcomes to brain death donors	6
Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis	6
Number of hepatocellular carcinoma nodules in patients listed for liver transplantation within alpha‐fetoprotein score: a new prognostic risk factor	6

Safety of intra‐operative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity score‐matched survival analysis	6
Temporal trends and impact of willingness to accept organs from donors with hepatitis C virus	6
A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS‐CoV‐2 infection	6
Sequential genetic testing of living‐related donors for inherited renal disease to promote informed choice and enhance safety of living donation	6
Implementation of the kidney team at home intervention: Evaluating generalizability, implementation process, and effects	6
Cancer transmissions and non‐transmissions from solid organ transplantation in an Australian cohort of deceased and living organ donors	6
Performance of modified Igls criteria to evaluate islet autograft function after total pancreatectomy with islet autotransplantation – a retrospective study	6
Development of ex situ normothermic reperfusion as an innovative method to assess pancreases after preservation	6
Short versus prolonged antibiotic treatment for complicated urinary tract infection after kidney transplantation	6
Current precautions and future directions in lung transplantation during the COVID‐19 pandemic – a single center cohort study	6
COVID‐19 in solid organ transplantation: an analysis of the impact on transplant activity and wait lists	6
Complications of polytetrafluoroethylene graft use in middle hepatic vein reconstruction in living donor liver transplantation: a retrospective, single‐centre, long‐term, real‐world experience	6
Relative and absolute cancer risks among Nordic kidney transplant recipients—a population‐based study	6
What happens after graft loss? A large, long‐term, single‐center observation	6
Organ transplantation and the European Union, 2009–2015 developments	6
Changing patterns of clinical decision making: are falling numbers of antibody incompatible transplants related to the increasing success of the UK Living Kidney Sharing Scheme? A national cohort stud	6
Outcomes with alemtuzumab induction therapy in lung transplantation: a comprehensive large‐scale single‐center analysis	5
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation – a multicenter cohort study	5
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference	5
A meta‐analysis of the cumulative incidence, risk factors, and clinical outcomes associated with chronic kidney disease after liver transplantation	5
The prognostic significance of serum aspartate transaminase and gamma‐glutamyl transferase in liver deceased donors	5
Steep neutrophil recovery following unrelated bone marrow transplantation is a major risk factor for the development of acute graft‐vs‐host disease—a retrospective study	5
Usefulness of an organ donation opinion survey as a tool to promote organ donation among the adolescent population	5
Efficacy and safety of conventional antiviral agents in preventive strategies for cytomegalovirus infection after kidney transplantation: a systematic review and network meta‐analysis	5
Management of early hepatic artery thrombosis following living‐donor liver transplantation: feasibility, efficacy and potential risks of endovascular therapy in the first 48 hours post‐transplant–a re	5
Association between primary graft dysfunction and acute kidney injury after orthotopic heart transplantation – a retrospective, observational cohort study	5
C3d‐positive donor‐specific antibodies have a role in pretransplant risk stratification of cross‐match‐positive HLA‐incompatible renal transplantation: United Kingdom multicentre study	5
Allograft nephrectomy versus nonallograft nephrectomy after failed renal transplantation: a systematic review by updated meta‐analysis	5
Strategies for prevention and control of the 2019 novel coronavirus disease in the department of kidney transplantation	5
Early detection of SARS‐CoV‐2 and other infections in solid organ transplant recipients and household members using wearable devices	5
Kidney paired donation in Brazil – a single center perspective	5
Contemporary look at extracorporeal membrane oxygenation as a bridge to reoperative lung transplantation in the United States – a retrospective study	5
A meta‐analysis on the incidence of donor‐related depression after liver transplant	5
Anticoagulation practices in total pancreatectomy with autologous islet cell transplant patients: an international survey of clinical programs	5
Urinary sulfate excretion and risk of late graft failure in renal transplant recipients – a prospective cohort study	5
Pretransplantation splenomegaly frequently persists after liver transplantation and can manifest as hypersplenism and graft fibrosis ‐ a retrospective study	5
Assessment of the Banff Working Group classification of definitive BK polyomavirus nephropathy	5
Impact of kidney transplant type and previous transplant on baseline donor‐derived cell free DNA	5
Enteric dysbiosis in liver and kidney transplant recipients: a systematic review	5
Access of non‐residents to transplantation of deceased donor organs: practices and strategies in the European setting	5
Crossing borders to facilitate live donor kidney transplantation: the Czech‐Austrian kidney paired donation program – a retrospective study	5
Comparison of pregnancy outcomes in Dutch kidney recipients with and without calcineurin inhibitor exposure: a retrospective study	5
Outcome of kidney transplantation from very senior donors in Switzerland – a national cohort study	5
Living well with kidney disease by patient and care partner empowerment: kidney health for everyone everywhere	5
Significance of phenotype change after chronic lung allograft dysfunction onset	5
Extraperitoneal kidney transplantation: a comparison between children weighting ≤15 kg and >15 kg. Experience of a single institution	5
Prolonged immunosuppression does not improve risk of sensitization or likelihood of retransplantation after kidney transplant graft failure	5
Improving the predictability of time to death in controlled donation after circulatory death lung donors	5
Stenting the ureteroneocystostomy reduces urological complications in kidney transplantation: a noninferiority randomized controlled trial, SPLINT trial	5
Long‐term kidney function and survival in recipients of allografts from living kidney donors with hypertension: a national cohort study	5
High trough levels of everolimus combined to sorafenib improve patients survival after hepatocellular carcinoma recurrence in liver transplant recipients	5
Successful surgical weight loss with laparoscopic sleeve gastrectomy for morbid obesity prior to kidney transplantation	5
Relevance of KDPI value and acute rejection on kidney transplant outcomes in recipients with delayed graft function – a retrospective study	5
Impact of changing renal function, while waiting for a heart transplant, on post‐transplant mortality and development of end stage kidney disease	5
The effect of organ preservation solutions on short‐term outcomes after liver transplantation: a single‐center retrospective study	5
Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial	4
Extreme hyponatremia as a risk factor for early mortality after liver transplantation in the MELD‐sodium era	4
Solid organ transplantation during the COVID‐19 pandemic in the United States	4
MiR‐339 and galectin‐3: diagnostic value in patients with airway obstruction after lung transplantation	4
The weekend effect in kidney transplantation outcomes: a French cohort‐based study	4
Risk factors for Epstein–Barr virus reactivation after renal transplantation: Results of a large, multi‐centre study	4
Simultaneous liver transplant and sleeve gastrectomy not associated with worse index admission outcomes compared to liver transplant alone – a retrospective cohort study	4
Selected liver grafts from donation after circulatory death can be safely used for retransplantation – a multicenter retrospective study	4
Patient and center characteristics associated with kidney transplant outcomes: a binational registry analysis	4
Efficacy of single‐agent immunosuppressive regimens in a murine model of vascularized composite allotransplantation	4
Donor age (≥45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation – a multicenter retrospective study	4
Liver transplantation versus watchful waiting in hepatocellular carcinoma patients with complete response to bridging therapy – a retrospective observational study	4
Post‐kidney transplant serum magnesium exhibits a U‐shaped association with subsequent mortality: an observational cohort study	4
Short‐ and long‐term impact of neutropenia within the first year after kidney transplantation	4
Seasonal trends in donor heart availability: an analysis of the UNOS database	4
Two‐year protocol biopsy after kidney transplantation in clinically stable recipients – a retrospective study	4
The COVID‐19 second wave risk and liver transplantation: lesson from the recent past and the unavoidable need of living donors	4
Critical pathway for deceased tissue donation: a novel adaptative European systematic approach	4
The potential role of antibodies against minor blood group antigens in renal transplantation	4
Bone densitometry versus bone histomorphometry in renal transplanted patients: a cross‐sectional study	4
Advanced donor age does not increase risk of hepatocellular carcinoma recurrence after liver transplantation: a retrospective two‐centre analysis using competing risk analysis	4
The relationship between proteinuria and allograft survival in patients with transplant glomerulopathy: a retrospective single‐center cohort study	4
HCC recurrence in HCV‐infected patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs – a post‐hoc analysis	4
Observational study of risk factors associated with clinical outcome among elderly kidney transplant recipients in Sweden – a decade of follow‐up	4
Increased rejection rates in kidney transplantations during the COVID‐19 pandemic	4
Early perioperative fluid overload is associated with adverse outcomes in deceased donor kidney transplantation	4
Predicting recurrence of hepatocellular carcinoma after liver transplantation using a novel model that incorporates tumor and donor‐related factors	4
An increase in kidney transplantation procedures from deceased donors during the COVID‐19 epidemic in Slovenia	4
Care of asymptomatic SARS‐CoV‐2 positive kidney transplant recipients	4
Comparison of live donor predonation and post‐transplant kidney volumes and glomerular size in pediatric patients weighing less than 15 kg – a retrospective study	4
Donor’s graft ex vivo T‐cell depletion with fludarabine reduces graft‐versus‐host disease signs and improves survival after intestinal transplantation – an experimental	4
Donor diabetes mellitus is a risk factor for diminished outcome after liver transplantation: a nationwide retrospective cohort study	4
SARS‐CoV‐2 pandemic and the need for transplant‐oriented trials	4
Clinical consequences of primary CMV infection after renal transplantation: a case–control study	4
Impacts of single nucleotide polymorphisms in Fc gamma receptor IIA ( rs1801274 ) on lung transplant outcomes among Japanese lung transplant recipients	4
Online education about end‐of‐life care and the donation process after brain death and circulatory death. Can we influence perception and attitudes in critical care doctors? A prospective study	4
Outcomes of ABO‐incompatible kidney transplantation in older patients: a national cohort study	3
One more time, emphasizing the advantage of simultaneous pancreas and kidney transplantation for patients with type 1 diabetes and end‐stage renal disease	3
Venous outflow congestion is related to poor recurrence‐free survival of living donor liver transplantation recipients with hepatocellular carcinoma – a retrospective study	3
Task force groups of Transplant International: working together to globally connect the transplant community of tomorrow	3